Literature DB >> 11819801

A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.

J You1, L Zhuang, B Z Tang, W B Yang, S Y Ding, W Li, R X Wu, H L Zhang, Y M Zhang, S M Yan, L Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11819801      PMCID： PMC4688733          DOI： 10.3748/wjg.v7.i3.411

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  21 in total

1.  Study on the quality of recombinant proteins using matrix-assisted laser desorption ionization time of flight mass spectrometry.

Authors:  Guo-Hua Zhou; Guo-An Luo; Ya-Cheng Cao; Ming-Sheng Zhu
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.

Authors:  J Fevery; A Elewaut; P Michielsen; F Nevens; P Van Eyken; M Adler; V Desmet
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

Review 3.  Thymic hormones--a clinical update.

Authors:  M B Sztein; A L Goldstein
Journal:  Springer Semin Immunopathol       Date:  1986

4.  Effect of cytokines on liver necrosis.

Authors:  Yan-Yan Yu; Chong-Wen Si; Xiu-Lan Tian; Qun He; Hai-Peng Xue
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

5.  Establishment of a nonradioactive assay for 2'-5' oligoadenylate synthetase and its application in chronic hepatitis C patients receiving interferon-alpha

Authors:  Wen-Bin Tong; Chun-Ying Zhang; Bai-Fang Feng; Qi-Min Tao
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

Review 6.  Thymosins: structure, function and therapeutic applications.

Authors:  T L Low; A L Goldstein
Journal:  Thymus       Date:  1984

7.  Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.

Authors:  G Marinos; F Torre; S Chokshi; M Hussain; B E Clarke; D J Rowlands; A L Eddleston; N V Naoumov; R Williams
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

8.  A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.

Authors:  P Andreone; C Cursaro; A Gramenzi; C Zavagliz; I Rezakovic; E Altomare; R Severini; J S Franzone; O Albano; G Ideo; M Bernardi; G Gasbarrini
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.

Authors:  S L Tsai; M H Chen; C T Yeh; C M Chu; A N Lin; F H Chiou; T H Chang; Y F Liaw
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 10.  Immune response to hepatitis B virus proteins: relevance of the murine model.

Authors:  D R Milich
Journal:  Semin Liver Dis       Date:  1991-05       Impact factor: 6.115
View more
  7 in total

1.  Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization.

Authors:  Yui-Jie Bai; Jin-Rong Zhao; Guan-Ting Lv; Wen-Hong Zhang; Yan Wang; Xiao-Jun Yan
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.

Authors:  Jing You; Lin Zhuang; Hong-Ying Cheng; Shou-Ming Yan; Lan Yu; Jun-Hua Huang; Bao-Zhang Tang; Meng-Ling Huang; Yong-Liang Ma; Virasakdi Chongsuvivatwong; Hutcha Sriplung; Alan Geater; Yan-Wei Qiao; Rong-Xue Wu
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

3.  Advances in the Treatment of Hepatitis B and Hepatitis C Nonresponders: A Report of Symposia Presented at the 15th Conference of the Asian Pacific Association for the Study of the LiverAugust 18-21, 2005Bali, Indonesia.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

Review 4.  Chronic hepatitis B: A wave of new therapies on the horizon.

Authors:  Timothy M Block; Siddhartha Rawat; Carol L Brosgart
Journal:  Antiviral Res       Date:  2015-06-22       Impact factor: 5.970

5.  Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice.

Authors:  Guo-Liang Zhang; Ye-Hong Wang; Wei Ni; Hui-Ling Teng; Zhi-Bin Lin
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B.

Authors:  Zheng-Wen Liu; Qun-Ying Han; Ni Zhang; Wen Kang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

7.  Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.

Authors:  Hong-Lei Han; Zhen-Wei Lang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.